Moderna, Inc. (NASDAQ: MRNA) Investment Insights
Moderna(US:MRNA) Financial Modeling Prep·2025-12-12 08:02Jefferies sets a modest price target increase for Moderna, Inc. (NASDAQ: MRNA), indicating a potential 1.28% growth.Investment firm Amundi significantly reduces its stake in Moderna, contrasting with other firms like Natixis Advisors LLC and Charles Schwab Investment Management Inc., which increased their holdings.Despite varying investment strategies, Moderna's stock price has experienced a 2.03% increase, with a market capitalization of approximately $11.57 billion.Moderna, Inc. (NASDAQ: MRNA) is a biotec ...